Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Axogen Inc (AXGN)

Axogen Inc (AXGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 688,285
  • Shares Outstanding, K 44,008
  • Annual Sales, $ 159,010 K
  • Annual Income, $ -21,720 K
  • EBIT $ -9 M
  • EBITDA $ -2 M
  • 60-Month Beta 1.06
  • Price/Sales 4.33
  • Price/Cash Flow N/A
  • Price/Book 6.90

Options Overview Details

View History
  • Implied Volatility 80.13% ( -25.45%)
  • Historical Volatility 47.85%
  • IV Percentile 45%
  • IV Rank 33.60%
  • IV High 215.06% on 05/02/24
  • IV Low 11.85% on 08/13/24
  • Put/Call Vol Ratio 0.60
  • Today's Volume 8
  • Volume Avg (30-Day) 50
  • Put/Call OI Ratio 0.02
  • Today's Open Interest 1,667
  • Open Int (30-Day) 2,154

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.06
  • Number of Estimates 3
  • High Estimate -0.05
  • Low Estimate -0.07
  • Prior Year -0.09
  • Growth Rate Est. (year over year) +33.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
13.10 +22.75%
on 11/25/24
16.48 -2.43%
on 12/23/24
+2.74 (+20.54%)
since 11/22/24
3-Month
11.51 +39.70%
on 11/07/24
16.48 -2.43%
on 12/23/24
+2.11 (+15.10%)
since 09/23/24
52-Week
5.55 +189.73%
on 05/06/24
16.48 -2.43%
on 12/23/24
+9.08 (+129.71%)
since 12/22/23

Most Recent Stories

More News
Here's Why you Should Retain Nevro Stock in Your Portfolio Now

Nevro NVRO is well-poised for growth in the coming quarters, courtesy of its technological innovations and diversification plans regarding its product portfolio. The optimism, led by a solid third-quarter...

AXGN : 16.00 (+2.30%)
NVRO : 3.71 (-2.11%)
ARAY : 1.8400 (-0.54%)
MASI : 167.16 (-1.39%)
Here's Why You Should Add Glaukos Stock to Your Portfolio Now

Glaukos Corporation GKOS is well-poised for growth on the back of favorable clinical trial results and a robust product pipeline. However, stiff competition is a concern.Shares of this Zacks Rank #2 (Buy)...

AXGN : 16.00 (+2.30%)
ARAY : 1.8400 (-0.54%)
MASI : 167.16 (-1.39%)
GKOS : 147.64 (-2.15%)
HealthEquity Stock Falls Despite Q3 Earnings and Revenue Beat

HealthEquity, Inc. HQY reported adjusted earnings per share (EPS) of 78 cents in third-quarter fiscal 2025, surpassing the Zacks Consensus Estimate by 9.86%. The bottom line improved 30% on a year-over-year...

AXGN : 16.00 (+2.30%)
HQY : 94.24 (-0.75%)
ARAY : 1.8400 (-0.54%)
MASI : 167.16 (-1.39%)
Here's Why You Should Add Accuray Stock in Your Portfolio Now

Accuray Incorporated ARAY is well-poised for growth in the coming quarters, courtesy of continued robust demand for its products. The optimism, led by robust international performance in the first quarter...

AXGN : 16.00 (+2.30%)
ARAY : 1.8400 (-0.54%)
MASI : 167.16 (-1.39%)
ANGO : 8.76 (-1.46%)
Reasons to Retain DENTSPLY SIRONA Stock in Your Portfolio Now

DENTSPLY SIRONA XRAY is well-poised for growth due to its robust product portfolio and continued focus on research and development. However, forex remains a concern.Shares of this Zacks Rank #3 (Hold)...

AXGN : 16.00 (+2.30%)
ARAY : 1.8400 (-0.54%)
MASI : 167.16 (-1.39%)
XRAY : 18.78 (+0.43%)
Reasons to Retain Inari Medical Stock in Your Portfolio for Now

Inari Medical, Inc. NARI is well poised for growth on the back of a huge market opportunity for its products and its commitment to understanding the venous system. However, the company’s dependency...

AXGN : 16.00 (+2.30%)
ARAY : 1.8400 (-0.54%)
MASI : 167.16 (-1.39%)
NARI : 54.08 (-2.47%)
AxoGen: Q3 Earnings Snapshot

AxoGen: Q3 Earnings Snapshot

AXGN : 16.00 (+2.30%)
Axogen, Inc Reports Third Quarter 2024 Financial Results and Provides BLA Update

AXGN : 16.00 (+2.30%)
Axogen, Inc. to report third quarter 2024 financial results and host conference call on November 7, 2024

AXGN : 16.00 (+2.30%)
Here's Why You Should Retain Penumbra Stock in Your Portfolio Now

Penumbra, Inc. PEN is likely to grow in the coming quarters, backed by the strength exhibited in the Thrombectomy business. The company’s robust portfolio expansion looks promising. However, the impact...

AXGN : 16.00 (+2.30%)
PEN : 239.21 (-1.37%)
PAHC : 21.60 (-0.41%)
TMDX : 63.02 (+2.14%)

Business Summary

AxoGen, Inc. engages in developing and marketing surgical solutions for peripheral nerves. The company's portfolio of products includes Avance Nerve Graft(R), AxoGuard Nerve Connector(R), AxoGuard Nerve Protector(R), Avive Soft Tissue Membrane(R), AcroVal Neurosensory & Motor Testing System(R) and AxoTouch...

See More

Key Turning Points

3rd Resistance Point 17.52
2nd Resistance Point 16.71
1st Resistance Point 16.17
Last Price 16.00
1st Support Level 14.82
2nd Support Level 14.01
3rd Support Level 13.47

See More

52-Week High 16.48
Last Price 16.00
Fibonacci 61.8% 12.30
Fibonacci 50% 11.01
Fibonacci 38.2% 9.73
52-Week Low 5.55

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar